{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:06:02Z","timestamp":1771232762859,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11102-015-0700-3","type":"journal-article","created":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T05:28:54Z","timestamp":1451712534000},"page":"251-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study"],"prefix":"10.1007","volume":"19","author":[{"given":"Lakshminarayanan","family":"Varadhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul C.","family":"Reulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,2]]},"reference":[{"key":"700_CR1","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","volume":"90","author":"R Kauppinen-Makelin","year":"2005","unstructured":"Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J, Voutilainen E (2005) A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 90:4081\u20134086","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102\u2013152","journal-title":"Endocr Rev"},{"key":"700_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","volume":"12","author":"L Alexander","year":"1980","unstructured":"Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71\u201379","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR4","first-page":"1","volume":"39","author":"AD Wright","year":"1970","unstructured":"Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. Q J Med 39:1\u201316","journal-title":"Q J Med"},{"key":"700_CR5","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","volume":"83","author":"A Abosch","year":"1998","unstructured":"Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411\u20133418","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1507\/endocrj.50.163","volume":"50","author":"K Arita","year":"2003","unstructured":"Arita K, Kurisu K, Tominaga A, Eguchi K, Iida K, Uozumi T, Kazagi F (2003) Mortality in 154 surgically treated patients with acromegaly\u2014a 10-year follow-up survey. Endocr J 50:163\u2013172","journal-title":"Endocr J"},{"key":"700_CR7","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","volume":"88","author":"R Cozzi","year":"2003","unstructured":"Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M, Albizzi M, Dallabonzana D, Pedroncelli AM (2003) Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinol Metab 88:3090\u20133098","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR8","doi-asserted-by":"crossref","first-page":"821579","DOI":"10.1155\/2012\/821579","volume":"2012","author":"JD Rolston","year":"2012","unstructured":"Rolston JD, Blevins LS Jr (2012) Gamma knife radiosurgery for acromegaly. Int J Endocrinol 2012:821579. doi: 10.1155\/2012\/821579","journal-title":"Int J Endocrinol"},{"key":"700_CR9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","volume":"342","author":"PJ Trainer","year":"2000","unstructured":"Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171\u20131177","journal-title":"N Engl J Med"},{"key":"700_CR10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","volume":"89","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89:1613\u20131617","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","volume":"58","author":"C Beauregard","year":"2003","unstructured":"Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86\u201391","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR13","first-page":"293","volume":"86","author":"AS Bates","year":"1993","unstructured":"Bates AS, Van\u2019t Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment in acromegaly. Q J Med 86:293\u2013299","journal-title":"Q J Med"},{"key":"700_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93:61\u201367","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2265.1995.tb02913.x","volume":"43","author":"D Jenkins","year":"1995","unstructured":"Jenkins D, O\u2019Brien I, Johnson A, Shakespear R, Sheppard MC, Stewart PM (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clin Endocrinol (Oxf) 43:517\u2013522","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR16","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F (2004) Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789\u20132796","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR17","first-page":"3419","volume":"83","author":"B Swearingen","year":"1998","unstructured":"Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419\u20133426","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR18","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2004-0530","volume":"89","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, Sheppard MC, Clayton RN, Bates AS, Stewart PM (2004) Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking. J Clin Endocrinol Metab 89:5867\u20135868","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425\u2013431","journal-title":"Lancet"},{"key":"700_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Rosen","year":"1990","unstructured":"Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285\u2013288","journal-title":"Lancet"},{"key":"700_CR21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/jc.2013-2450","volume":"99","author":"M Sherlock","year":"2014","unstructured":"Sherlock M, Reulen RC, Aragon-Alonso A, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM (2014) A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk. J Clin Endocrinol Metab 99:478\u2013485","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04019.x","volume":"75","author":"CN Jayasena","year":"2011","unstructured":"Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS (2011) The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Clin Endocrinol (Oxf) 75:220\u2013225","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294\u2013302","journal-title":"Pituitary"},{"key":"700_CR24","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94:4216\u20134223","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","volume":"223","author":"BA Bengtsson","year":"1988","unstructured":"Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B (1988) Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327\u2013335","journal-title":"Acta Med Scand"},{"key":"700_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M, Italian Study Group of Acromegaly (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167:189\u2013198","journal-title":"Eur J Endocrinol"},{"key":"700_CR27","first-page":"2730","volume":"83","author":"SM Orme","year":"1998","unstructured":"Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730\u20132734","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR28","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1210\/jc.2007-2149","volume":"93","author":"L Nachtigall","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93:2035\u20132041","journal-title":"J Clin Endocrinol Metab"},{"key":"700_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.12112","volume":"79","author":"S Vallette","year":"2013","unstructured":"Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Van Uum S, Rivera J, Caspar-Bell G, Serri O (2013) Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf) 79:79\u201385","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/cen.12685","volume":"82","author":"CN Jayasena","year":"2015","unstructured":"Jayasena CN, Izzi-Engbeaya C, Narayanaswamy S, Modi M, Clarke H, Nijher GM, Meeran K, Dhillo WS (2015) Associations of coefficient of variation of serum GH with previous radiotherapy, hypopituitarism and cardiac disease in patients with treated acromegaly. Clin Endocrinol (Oxf) 82:870\u2013875","journal-title":"Clin Endocrinol (Oxf)"},{"key":"700_CR31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/0028-3886.158210","volume":"63","author":"P Dutta","year":"2015","unstructured":"Dutta P, Hajela A, Pathak A, Bhansali A, Radotra BD, Vashishta RK, Korbonits M, Khandelwal N, Walia R, Sachdeva N, Singh P, Murlidharan R, Devgun JS, Mukherjee KK (2015) Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: impact of a multi-disciplinary team. Neurol India 63:360\u2013368","journal-title":"Neurol India"},{"key":"700_CR32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-14-0844","volume":"172","author":"C Schofl","year":"2015","unstructured":"Schofl C, Grussendorf M, Honegger J, Tonjes A, Thyroke-Gronostay D, Mayr B, Schopohl J, Participants of German Acromegaly Register (2015) Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey. Eur J Endocrinol. 172:351\u2013356","journal-title":"Eur J Endocrinol."},{"key":"700_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-12-0602","volume":"168","author":"C Schofl","year":"2012","unstructured":"Schofl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B, Mayr B, Schopohl J, Participants of the German Acromegaly Register (2012) Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol. 168:39\u201347","journal-title":"Eur J Endocrinol."}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-015-0700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0700-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T03:57:31Z","timestamp":1567483051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-015-0700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,2]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["700"],"URL":"https:\/\/doi.org\/10.1007\/s11102-015-0700-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,2]]}}}